Abstract
AbstractThe cytoplasm of myeloma cells is rich in ribose nucleic acid. The basophilic inclusion bodies which develop in myeloma cells under the influence of stilbamidine contain ribose nucleic acid. The myeloma tissue of patients treated with stilbamidine contains appreciable amounts of stilbamidine.There is reason to believe that the nucleoproteins of myeloma cells differ from the nucleoproteins of other cells. This could explain why stilbamidine reacts with the nucleoproteins of myeloma cells only, and not with the nucleoproteins of other cells.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
